Machine-learning-guided screening discovers potent innate immune signaling modulators
At the University of Chicago, an active-learning pipeline iteratively selected molecules from a 139,998-compound library for in-vitro assays of NF-κB and interferon regulatory factor (IRF) signaling. After screening about 2% of the library, the study reported compounds suppressing NF-κB up to 15-fold or elevating NF-κB and IRF up to 5-fold and 6-fold, respectively. Follow-up cytokine assays found PME-4007 increased IFN-β secretion about threefold when co-delivered with the STING agonist cGAMP.
Technology: Machine-learning active-learning pipeline with variational-autoencoder molecular representations, Gaussian-process regression and Bayesian optimization
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: At the University of Chicago, an active-learning pipeline iteratively selected molecules from a 139,998-compound library for in-vitro assays of NF-κB and interferon regulatory factor (IRF) signaling.
- Still unknown: The work reports in-vitro pathway modulation and primary-cell cytokine assays, not vaccination, immunotherapy efficacy, animal outcomes or clinical benefit. Fold changes are study-specific relative to agonist-only controls. A subset of candidates was further characterized; four tested compounds were flagged as non-viable by the cytostasis/cytotoxicity confluency mask despite strong pathway effects.
- AI role: Models were iteratively trained on screening measurements and used Bayesian optimization to select subsequent compounds for in-vitro testing. This model-guided selection led to the reported NF-κB/IRF modulators; follow-up cytokine release assays tested a subset.
Evidence sources: https://pubmed.ncbi.nlm.nih.gov/38020385/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: at percentile 86 of works of the same type, year and subfield (OpenAlex work metrics, 21 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.